Nathaniel David's Insider Trades & SAST Disclosures
Nathaniel David's most recent trade in Unity Biotechnology Inc was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nathaniel David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Unity Biotechnology Inc | Nathaniel E. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Nathaniel E. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Nathaniel E. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Nathaniel David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Nathaniel David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Nathaniel David | Director, President | Sale of securities on an exchange or to another person at price $ 5.24 per share. | 16 Dec 2020 | 1,700,000 | 624,703 (1%) | 3% | 5.2 | 8,908,000 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Nathaniel David | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.67 per share. | 22 Jun 2020 | 2,483 | 2,324,703 (5%) | 0% | 9.7 | 24,011 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Nathaniel David | Director, President | Purchase of securities on an exchange or from another person at price $ 8.90 per share. | 05 Jun 2020 | 3,200 | 2,327,186 (5%) | 0% | 8.9 | 28,478 | Common Stock, $0.0001 par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges